Novo Nordisk

While American drug companies Merck (MRK) and Pfizer (PFE) aren’t doing well (or at least Merck has bounced off its deep lows rather nicely), check out the performance of Denmark’s Novo Nordisk (NVO):

The stock is up about $5 a share today to $106. I had to cut off the top part of the chart because it’s a logarithmic scale, but you get the idea.

Posted by Eddy Elfenbein on June 21st, 2007 at 11:47 am

The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.